Examkin

Soru

Zorluk: Çok zorMonitoring and Treatment Evaluation

A 29-year-old woman is admitted to the medical ward for an acute flare of known ulcerative colitis. On admission, she reports 11 bloody bowel movements per day. Her vital signs show a heart rate of 115/min, blood pressure of 110/70 mm Hg, and a temperature of 38.1°C (100.6°F). Laboratory results reveal a hemoglobin of 9.8 g/dL and a C-reactive protein (CRP) of 65 mg/L. The patient is designated as having acute severe ulcerative colitis. Arrange the following steps in the optimal sequential protocol for her diagnostic evaluation, treatment monitoring, and therapeutic escalation.

  1. 1Exclude concurrent superinfections by obtaining stool assays for Clostridioides difficile and performing a flexible sigmoidoscopy to evaluate for cytomegalovirus.
  2. 2Administer high-dose intravenous corticosteroids (e.g., methylprednisolone) as first-line medical therapy while monitoring stool frequency and vital signs.
  3. 3Evaluate treatment efficacy at day 3 to 5 using validated clinical metrics (e.g., stool frequency and CRP levels) to assess for steroid refractoriness.
  4. 4Initiate medical rescue therapy with a biologic agent (e.g., infliximab) or intravenous cyclosporine.
  5. 5Monitor response to rescue therapy over the subsequent 4 to 7 days while preparing for an urgent subtotal colectomy if symptoms remain refractory.

Cevap

The correct sequence for managing and monitoring acute severe ulcerative colitis is: 1) Exclude concurrent superinfections, 2) Initiate intravenous corticosteroids, 3) Evaluate treatment efficacy at day 3 to 5, 4) Initiate medical rescue therapy if refractory, and 5) Monitor rescue therapy response while preparing for potential urgent colectomy.
The protocol for acute severe ulcerative colitis relies heavily on strict temporal monitoring and sequential treatment evaluation to prevent catastrophic complications like toxic megacolon. Management inherently begins with excluding superinfections (e.g., C. difficile or cytomegalovirus) that could mimic a flare or significantly worsen with profound immunosuppression. Once these are excluded, intravenous corticosteroids are initiated. A critical decision point occurs at day 3 to 5 of steroid therapy; objective markers (such as stool frequency and CRP) must be evaluated to determine if the patient is steroid-refractory. If the patient is deemed refractory at this specific milestone, prompt escalation to medical rescue therapy (infliximab or cyclosporine) is indicated. Finally, if the patient fails to improve on rescue therapy over the subsequent 4 to 7 days, surgical intervention (subtotal colectomy) is the definitive next step. Adhering to these rigid monitoring intervals prevents dangerous delays in escalating to life-saving surgical care.

Adım Adım Çözüm

1
Identify the presentation as acute severe ulcerative colitis based on clinical criteria (e.g., >6 bloody stools/day plus systemic toxicity) and order infectious workup including C. difficile toxin and flexible sigmoidoscopy.
Superinfections like cytomegalovirus or C. difficile are effectively ruled out.
High-dose immunosuppressants can be fatal if an active, undiagnosed infection is present.
2
Start intravenous methylprednisolone and monitor objective daily parameters.
The initial inflammatory cascade is suppressed in the majority of patients.
Intravenous corticosteroids represent the standard, rapid-acting first-line therapy for acute severe exacerbations.
3
Re-evaluate the patient's clinical trajectory on days 3 to 5 using strict criteria (e.g., stool frequency and CRP).
The patient is formally categorized as either steroid-responsive or steroid-refractory.
Prolonging ineffective corticosteroids increases surgical morbidity; utilizing a strict timeline prevents the delay of necessary therapeutic escalation.
4
Administer infliximab or cyclosporine for steroid-refractory cases and continue close clinical monitoring.
Second-line medical rescue therapy is attempted to halt disease progression.
These powerful agents can induce remission and avoid surgery in a subset of steroid-refractory patients.
5
Engage surgical consultation for subtotal colectomy if rescue therapy fails after a short 4 to 7 day trial.
Definitive surgical management is prepared and executed if necessary.
Failure of medical rescue therapy carries an imminent high risk of toxic megacolon, perforation, and mortality, necessitating prompt surgical intervention.

Anahtar Kavram

Protocolized step-up management and strict timeline monitoring (e.g., day 3-5 assessment) in acute severe ulcerative colitis.
Bu soruyu puanla

Konular

Monitoring and Treatment Evaluation

Bu konudan daha fazla soru